Concurrent analysis of whole-genome DNA methylation and single-cell RNA sequencing data from COVID-19 patients and controls ...

Secretome Therapeutics, a pioneering company in the field of regenerative medicine, today announced that the U.S. Food and Drug Administration (FDA) has granted Fast Track designation to STM-01, the ...

Advances in tissue engineering offer hope for spinal cord injury repair, utilizing biomaterials, stem cells, and bioactive ...

The discovery of the high-risk cells — a subset of progenitor cells that reside in fallopian tube supportive tissue, or stroma — may pave the way for better approaches to prevent and detect high-grade ...

Recent Pre-Clinical Studies Showed BP1001-A Attenuated Fatty Acid-Induced Insulin Resistance and Restored Insulin Sensitivity in Muscle Progenitor and Skeletal Muscle Fiber Cell ModelsHOUSTON, March ...

Pomerantz LLP announces that a class action lawsuit has been filed against Geron Corporation ("Geron" or the "Company") and certain officers. The class action, filed in the United States District ...

In a major advancement for ovarian cancer research, a team of scientists from the University of Pittsburgh has identified ...

Lineage Cell Therapeutics (NYSEAMERICAN:LCTX – Free Report) had its price objective reduced by B. Riley from $4.00 to $3.00 in a research note released on Friday,Benzinga reports. They currently have ...

Scientists have uncovered a hidden driver of ovarian cancer—high-risk mesenchymal stem cells lurking in the fallopian tubes.

Researchers have discovered high-risk cells in fallopian tubes that could lead to high-grade serous ovarian cancer, paving ...

Pitt research uncovers new insights into ovarian cancer origins, shedding light on potential early detection and treatment ...